Year archive

Evolva Holding SA — 2021 filings

All 12 regulatory filings released by Evolva Holding SA (EVE) in 2021, sourced directly from the official regulator.

12 Filings

2021 Period

2021 filings (12)

Filing	Released	Lang
Evolva secures additional financing lines to accelerate its growth Capital/Financing Update	2021-12-27	English
Evolva announces private placement of 63.8m shares to VERAISON raising gross proceeds of CHF 7.5m and CFO departure Share Issue/Capital Change	2021-11-30	English
Evolva issued 40000000 shares out of authorized capital Share Issue/Capital Change	2021-09-27	English
Evolva accelerated revenue growth to 60% and expects gross profit to be positive from Q4, 2021 Earnings Release H1 2021	2021-08-26	English
Evolva secures additional funding for future growth Capital/Financing Update	2021-05-17	English
Evolva Q1 2021 Trading Update Earnings Release Q1 2021	2021-04-21	English
Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2021 AGM Information	2021-04-08	English
Evolva announces new Chief Financial Officer Board/Management Information	2021-03-24	English
Evolva publishes agenda for 2021 Annual General Meeting AGM Information	2021-03-16	English
Evolva announces Chief Financial Officer to depart Board/Management Information	2021-03-02	English
Evolva reports Full Year Results for 2020, with significant increase in customer demand for Health Ingredients and product expansion Earnings Release FY 2020	2021-02-25	English
Evolva launches L-arabinose, a natural sugar blocker and reducing sugar Regulatory Filings	2021-01-20	English